FL H0955

Creates s. 490.0065, F.S., authorizing the Board of Psychology to certify licensed psychologists to prescribe, administer, discontinue, or distribute drugs and controlled substances for psychiatric, mental, cognitive, nervous, emotional, developmental, or behavioral disorders, provided they hold a doctoral degree in psychology, pass a nationally recognized psychopharmacology examination, and complete specified didactic and clinical training consistent with American Psychological Association policies.

Requires prescribing psychologists to consult and concur with a patient's primary care physician before prescribing, altering, or discontinuing a drug, and prohibits issuing prescriptions to patients who lack a primary care physician or delegating prescribing authority to another person.

Mandates prescribing psychologists maintain at least $250,000 in professional liability insurance, file their DEA registration number with the board within 10 days of authorization to prescribe controlled substances, and complete 20 hours of prescriptive authority-related continuing education every 2-year licensure period.

Requires the Board of Psychology to establish a 5-member interim panel by October 1, 2024—composed of a psychiatrist, pediatrician, doctoral-level pharmacist, and two psychologists with psychopharmacology credentials—to develop a formulary and recommend proposed rules by February 1, 2025, with the panel dissolving May 1, 2025.

Amends s. 627.6131, F.S., to include psychologists licensed under chapter 490 among providers subject to the 12-month overpayment claim submission limit for health insurance claims, applicable to services provided on or after October 1, 2024.